Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [2];  [3];  [4]; ;  [1];  [2];  [2]
  1. Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk (Korea, Republic of)
  2. Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon (Korea, Republic of)
  3. Huons Research Center, Gyonggido (Korea, Republic of)
  4. Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, Daejeon (Korea, Republic of)

Obesity increases the risk of chronic liver diseases, including viral hepatitis, alcohol-induced liver disease, and non-alcoholic steatohepatitis. In this study, we investigated the effects of obesity in acute hepatic failure using a murine model of thioacetamide (TA)-induced liver injury. Genetically obese ob/ob mice, together with non-obese ob/+ littermates, were subjected to a single intraperitoneal injection of TA, and examined for signs of hepatic injury. ob/ob mice showed a significantly higher survival rate, lower levels of serum alanine aminotransferase and aspartate aminotransferase, and less hepatic necrosis and apoptosis, compared with ob/+ mice. In addition, ob/ob mice exhibited significantly lower levels of malondialdehyde and significantly higher levels of glutathione and antioxidant enzyme activities compared with their ob/+ counterparts. Bioactivation analyses revealed reduced plasma clearance of TA and covalent binding of [{sup 14}C]TA to liver macromolecules in ob/ob mice. Together, these data demonstrate that genetically obese mice are resistant to TA-induced acute liver injury through diminished bioactivation of TA and antioxidant effects. - Highlights: • ob/ob mice are resistant to lethal doses of thioacetamide, compared to ob/+ mice. • ob/ob mice show reduced oxidative stress and enhanced antioxidant enzyme activity. • ob/ob mice exhibit diminished bioactivation of thioacetamide.

OSTI ID:
22687879
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Vol. 291; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

The role of vitamin D3 upregulated protein 1 in thioacetamide-induced mouse hepatotoxicity
Journal Article · Mon Nov 01 00:00:00 EDT 2010 · Toxicology and Applied Pharmacology · OSTI ID:21451194

The role of osteopontin in D-galactosamine-induced liver injury in genetically obese mice
Journal Article · Sun Jan 31 23:00:00 EST 2010 · Toxicology and Applied Pharmacology · OSTI ID:21344857

Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity
Journal Article · Tue Mar 14 23:00:00 EST 2006 · Toxicology and Applied Pharmacology · OSTI ID:20783445